Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-29

Clinical Trial Update: Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing solifenacin/tamsulosin combination therapy to tamsulosin alone for lower urinary tract symptoms due to benign prostatic hyperplasia ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin (tamsulosin)
  • solifenacin/tamsulosin combination therapy

Snippet

Sponsor: Jeil Pharmaceutical Co., Ltd. | Conditions: Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED